$13.07
3.90% yesterday
Nasdaq, Oct 03, 10:00 pm CET
ISIN
US15687V1098
Symbol
CERT

Certara Stock price

$13.07
+2.57 24.48% 1M
+3.29 33.64% 6M
+2.42 22.72% YTD
+2.08 18.93% 1Y
-0.33 2.46% 3Y
-25.01 65.68% 5Y
-25.01 65.68% 10Y
-25.01 65.68% 20Y
Nasdaq, Closing price Fri, Oct 03 2025
-0.53 3.90%

Key metrics

Basic
Market capitalization
$2.1b
Enterprise Value
$2.2b
Net debt
$131.9m
Cash
$162.3m
Shares outstanding
160.6m
Valuation (TTM | estimate)
P/E
261.4 | 29.5
P/S
5.2 | 4.9
EV/Sales
5.5 | 5.2
EV/FCF
28.8
P/B
2.0
Financial Health
Equity Ratio
67.2%
Return on Equity
-1.1%
ROCE
1.8%
ROIC
1.4%
Debt/Equity
0.3
Financials (TTM | estimate)
Revenue
$405.8m | $430.2m
EBITDA
$81.3m | $134.5m
EBIT
$25.8m | $120.8m
Net Income
$8.0m | $71.3m
Free Cash Flow
$77.5m
Growth (TTM | estimate)
Revenue
11.6% | 11.7%
EBITDA
474.2% | 159.4%
EBIT
136.0% | 7,084.4%
Net Income
110.1% | 691.5%
Free Cash Flow
52.7%
Margin (TTM | estimate)
Gross
61.1%
EBITDA
20.0% | 31.3%
EBIT
6.4%
Net
2.0% | 16.6%
Free Cash Flow
19.1%
More
EPS
$0.1
FCF per Share
$0.5
Short interest
12.2%
Employees
2k
Rev per Employee
$250.0k
Show more

Is Certara a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,001 stocks worldwide.

Certara Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Certara forecast:

11x Buy
61%
7x Hold
39%

Analyst Opinions

18 Analysts have issued a Certara forecast:

Buy
61%
Hold
39%

Financial data from Certara

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
406 406
12% 12%
100%
- Direct Costs 158 158
6% 6%
39%
248 248
16% 16%
61%
- Selling and Administrative Expenses 131 131
13% 13%
32%
- Research and Development Expense 36 36
7% 7%
9%
81 81
474% 474%
20%
- Depreciation and Amortization 56 56
11% 11%
14%
EBIT (Operating Income) EBIT 26 26
136% 136%
6%
Net Profit 7.98 7.98
110% 110%
2%

In millions USD.

Don't miss a Thing! We will send you all news about Certara directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Certara Stock News

Neutral
Seeking Alpha
24 days ago
Certara, Inc. (NASDAQ:CERT ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 12:20 PM EDT Company Participants John Gallagher - SVP, Principal Accounting Officer & Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley, Research Division Presentation Craig Hettenbach VP & Equity Analyst All right. I think we're on time here.
Neutral
Seeking Alpha
25 days ago
Certara, Inc. (NASDAQ:CERT ) Baird Global Healthcare Conference 2025 September 9, 2025 10:15 AM EDT Company Participants William Feehery - CEO & Director John Gallagher - SVP, Principal Accounting Officer & Chief Financial Officer Conference Call Participants Joseph Vruwink - Robert W. Baird & Co. Incorporated, Research Division Presentation Joseph Vruwink Senior Research Analyst All right.
Neutral
GlobeNewsWire
about one month ago
RADNOR, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the availability of Pinnacle 21 Enterprise Plus.
More Certara News

Company Profile

Certara, Inc. engages in the provision of software and technology enables services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017 and is headquartered in Princeton, NJ.

Head office United States
CEO William Feehery
Employees 1,517
Founded 2008
Website www.certara.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today